MC Nicolson - Concepedia

Author

MC Nicolson

Royal Marsden NHS Foundation Trust

Also Known As

M C Nicolson, M Nicolson, M. Nicolson, M.C. Nicolson, MC Nicolson

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Royal Marsden NHS Foundation Trust Royal Marsden Hospital Institute of Cancer Research

About

MC Nicolson is an author at Royal Marsden NHS Foundation Trust specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	349
2	Health Sciences	3	3	63
3	Pathology	3	3	198
4	Obstetrics	2	2	68
5	Cell Biology	1	1	19

MC Nicolson

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. Andrew Webb, David Cunningham, J.H. Scarffe, Journal of Clinical Oncology	1997	872
A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF) Michael Findlay, David Cunningham, A. Norman, Annals of Oncology	1994	259
Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer PA Ellis, IE Smith, MC Nicolson, British Journal of Cancer Symptom ReliefAdvanced Lung DiseaseMitomycin CMedicineCancer Management	1995	175
Phase II study of continuous infusion fluorouracil and interferon alfa-2b in the palliation of malignant neuroendocrine tumors. Jervoise Andreyev, P. Scott-Mackie, David Cunningham, Journal of Clinical Oncology	1995	46
Haemostatic changes and thromboembolic risk during tamoxifen therapy in normal women Jones Al, T.J. Powles, J Treleaven, British Journal of Cancer ThrombosisHormonal ContraceptiveVenous ThrombosisCardiovascular DiseaseTamoxifen Therapy	1992	41
Comparison of Tirazone (Tirapazamine) and cisplatin vs. etoposide and cisplatin in advanced non-small cell lung cancer (NSCLC): Final results of the international Phase III CATAPULT II Trial Frances A. Shepherd, G. Koschel, Joachim von Pawel, Lung Cancer Final ResultsMedicineMetronomic TherapyPharmacologyBronchial Neoplasm	2000	28
Platinum-Taxol non-cross resistance in epithelial ovarian cancer ME Gore, Nancy Preston, Roger A’Hern, British Journal of Cancer Platinum-taxol Non-cross ResistanceMedicineGynecologyCancer BiologyCancer Treatment	1995	27
Continuous infusional topotecan in advanced breast and non-small-cell lung cancer: no evidence of increased efficacy PN Mainwaring, MC Nicolson, Tamas Hickish, British Journal of Cancer Breast OncologyNon-small-cell Lung CancerMedicineCancer ManagementAdvanced Breast	1997	23
Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin CF O'Neill, MC Nicolson, Cfj Barnard, British Journal of Cancer Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderPharmacology	1994	19
A randomised dose escalation study of subcutaneous interleukin 2 with and without levamisole in patients with metastatic renal cell carcinoma or malignant melanoma F.Y. Ahmed, GA Leonard, Roger A’Hern, British Journal of Cancer UrologySubcutaneous Interleukin 2MedicineMelanomaMetronomic Therapy	1996	13

Page 1